Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001017386-11-000055
Filing Date
2011-04-01
Accepted
2011-04-01 17:17:44
Documents
5
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 2010 ANNUAL REPORT - AMENDMENT NO. 1 bti_2010-10ka.htm 10-K/A 469797
2 CFO CERTIFICATION bti_exhibit32-2.htm EX-32.2 5194
3 CEO CERTIFICATION bti_exhibit31-1.htm EX-31.1 11521
4 CFO CERTIFICATION bti_exhibit31-2.htm EX-31.2 11400
5 CEO CERTIFICATION bti_exhibit32-1.htm EX-32.1 5211
  Complete submission text file 0001017386-11-000055.txt   504222
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-164785 | Film No.: 11732587
SIC: 2834 Pharmaceutical Preparations